Africa's No.1 Healthcare, Pharma & Biotech Industry Magazine
SWITZERLAND – Roche has secured the US Food and Drug Administration (FDA) 510(k) approval for cobas pure integrated solutions, its new-generation work area platform intended for low- to mid-volume labs.…
Read More
SOUTH AFRICA – Roche Pharmaceuticals South Africa has launched its human papillomavirus (HPV) self-sampling solution in countries accepting the CE mark, the multinational healthcare company said on its website. According…
Read More
SOUTH AFRICA – Roche Pharmaceuticals South Africa marks the World Lymphoma Awareness Day (WLAD) with calls to improve the ways lymphomas are diagnosed, treated and tracked as it is the…
Read More
SWITZERLAND – Pharmaceutical giant Roche will acquire Good Therapeutics, reeling in its lead program six years after the Seattle startup was founded to design drugs that operate only where needed…
Read More
SWITZERLAND – Roche has launched the Digital LightCycler System, its first digital polymerase chain reaction (PCR) system, to help clinical researchers better understand patients’ cancer, genetic diseases, or infections. Commenting…
Read More
SOUTH AFRICA – Roche Pharmaceuticals South Africa has launched its next-generation VENTANA DP 600 slide scanner for digital pathology to enhance patient care with precision diagnostics, the multinational healthcare company…
Read More
SWITZERLAND- The first digital polymerase chain reaction (PCR) machine from Roche has been made available for purchase, according to Swiss Pharma. This next-generation system is made to precisely measure minute…
Read More
SOUTH AFRICA – Roche Pharma South Africa has launched its newest advanced tissue staining platform dubbed the BenchMark ULTRA PLUS system for cancer diagnostics that enables pathologists to provide quick…
Read More
INDIA- Roche Pharma India in association with Sidney Kimmel Cancer Center (SKCC) has launched an Advanced Certification Program in Molecular Oncology (ACMO) to equip oncologists and pathologists in the country…
Read More
USA – Avista Therapeutics, a University of Pittsburgh Medical Center (UPMC) spinout, has entered a collaboration with Roche for developing new AAV gene therapy vectors for eyes. The alliance plans…
Read More